National Association of Testing Authorities, Australia
Scope of Accreditation
Territory Pathology
Site
Territory Pathology Alice Springs
Accreditation No.
3125
Site No.
3118
Date of Accreditation
22 Mar 1991
Address
Alice Springs Hospital, 6 Gap Road
Alice Springs, NT 870
Australia
Contact
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
31 Dec 2027
Last Activity Date
09 May 2024
Service | Product | Determinant |
---|---|---|
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Swabs; Urine | Snake venom detection |
Plasma; Serum | Ethanol; Paracetamol (acetaminophen); Salicylate | |
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Tacrolimus |
Plasma | Vancomycin | |
Plasma; Serum | Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium | |
Digoxin; Phenytoin (dilantin); Valproate (valproic acid, epilim) | ||
Serum | Vancomycin | |
Chemical pathology - Detection and/or quantitation of tumour markers | Faeces | Blood |
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Parathyroid hormone (PTH) |
Plasma; Serum | Cortisol | |
Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Chemical pathology - Further investigation of cardiac function | Plasma | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
Plasma; Serum | Troponin | |
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Protein - Total |
Plasma | Ammonia | |
Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Carbon dioxide (CO2); Chloride; Cholesterol - HDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; High sensitivity C-reactive protein (CRP); Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
Plasma; Serum; Urine | Osmolality | |
Urine | Albumin/creatinine ratio (ACR); Chloride; Creatinine; Potassium; Protein - Total; Sodium; Urea | |
Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12) |
Chemical pathology - Tests for thyroid function | Plasma | Thyroxine (T4) - Free |
Plasma; Serum | Thyroid stimulating hormone (TSH) | |
Serum | Thyroxine (T4) - Free | |
Haematology - Examination of blood films by special staining | Blood | Malaria |
Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
Haematology - Full blood examination | Blood | Differential number; Morphology |
Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Nucleated red blood cells (NRBC); Platelet count; Red blood cell index or indices; Reticulocytes | ||
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT) |
Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
Immunohaematology - Blood group antibody detection | Blood | Other blood group systems; Rh phenotypes |
Immunohaematology - Blood grouping | Blood | ABO; RhD |
Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
Other blood group antibodies; Red blood cell phenotyping; Rh | ||
Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Immunohaematology - Storage and distribution of blood and blood components | Blood; Cryoprecipitate; Fresh frozen plasma (FFP) | Compliance with transport, storage and distribution requirements of blood, products and components |
Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Rheumatoid factor |
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; General swabs; Genital swabs; Respiratory specimens; Sputum; Synovial fluid; Tissues; Urine | Antibiotic susceptibility |
Bacteria; Pathogenic microorganisms | ||
Bacteria; Pathogenic identification | ||
Bacteria; Pathogenic identification | ||
Aspirates; Blood; Cerebrospinal fluid (CSF); Fluids; General swabs; Genital swabs; Respiratory specimens; Sputum; Synovial fluid | Bacteria; Leucocytes (white blood cells, WBC) | |
Aspirates; Blood; Synovial fluid | Bacteria; Pathogenic microorganisms | |
Aspirates; Cerebrospinal fluid (CSF); Synovial fluid | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Blood | Pathogenic microorganisms | |
Faeces | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Glass slide | Leprosy (Hansen's disease) | |
Urine | Bacteria; Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Groin swabs; Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA) |
Rectal swabs | Vancomycin resistant Enterococci (VRE) | |
Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags | Bacterial growth - Sterility |
Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility | |
Bacterial growth - Sterility | ||
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Dry swabs; Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF) | Yeasts identification |
Genital swabs | Yeasts identification | |
Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Faeces | Cryptosporidia; Giardia spp. | |
Cysts; Ova; Parasites | ||
Genital swabs | Parasites | |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Infectious mononucleosis |
Serum | Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV); Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
3125
Site No.
3118
Print date
11 Nov 2024